Chad M Michener MD FACOG

Gynecologic Oncology

Vice Chair, Obstetrics/ Gynecology Institute | Chair, Dept of Subspecialty Care for Women’s Health | Professor of OB/GYN and Reproductive Biology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Join to View Full Profile

9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Fax+1 216-444-8551

Summary

-Vice Chair, Obstetrics and Gynecology Institute
-Chair, Dept of Subspecialty Care for Women’s Health
-Professor of Ob/Gyn and Reproductive Biology Cleveland Clinic Lerner College of Medicine of Case Western University.
-Fellow, American College of Obstetricians and Gynecologists and a member of the Society of Gynecologic Oncologists.
-Staff, Gynecologic Oncology

Education & Training

Cleveland Clinic FoundationFellowship, Gynecologic Oncology, 2002 - 2004
National Cancer InstitutePost-Doctoral Fellowship, 2001 - 2002
TriHealth (Bethesda Hospital)Residency, Obstetrics and Gynecology, 1997 - 2001
Wright State University Boonshoft School of MedicineClass of 1997

Certifications & Licensure

OH State Medical License 1998 - 2028
MD State Medical License 2001 - 2003
KY State Medical License 1999 - 2000
MN State Medical License 2000 - 2000
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017

Clinical Trials

Randomized Phase II Study of Intravenous 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, Triapine® NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and S Start of enrollment: 2013 Apr 01
Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery Start of enrollment: 2013 Jul 01
Terminated
Not Applicable
A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) Start of enrollment: 2019 Mar 20
Completed
Phase 2

Publications & Presentations

PubMed

Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer.
Laura M Chambers, Julia Chalif, Meng Yao, Ofer Reizes, Peter G Rose
Journal of Gynecologic Oncology. 2026-01-01
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinoma.
Peter G Rose, Sujata Patil, Meng Yao, Laura M Chambers, Robert DeBernardo
International Journal of Gynecological Cancer. 2025-12-31
18 citations
Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy in High-Grade Epithelial Ovarian Cancer: A LANCE Randomized Clinical Trial.
J Alejandro Rauh-Hain, Alexander Melamed, René Pareja, Taymaa May, Abdulrahman Sinno
JAMA Network Open. 2024-11-04

Press Mentions

Phase II Trials Evaluate Topical Treatment for Vulvar and Cervical DysplasiasOctober 7th, 2025
Hillcrest Hospital Opens New Obstetrics Emergency DepartmentNovember 26th, 2021
Cleveland Clinic Names Tristi Muir, M.D., Chair of Ob/Gyn & Women’s Health InstituteSeptember 8th, 2021